96 related articles for article (PubMed ID: 26518963)
1. Effects of Fetal and Neonatal Murine Peripheral Blood Mononuclear Cells Infusion on MicroRNA-145 Expression in Renal Vascular Smooth Muscle Cells in MRL/lpr Mice.
Wen C; Liu XY; Wan WQ; Yi ZW
Transplant Proc; 2015 Oct; 47(8):2523-7. PubMed ID: 26518963
[TBL] [Abstract][Full Text] [Related]
2. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-181d-5p regulates the MAPK signaling pathway by targeting mitogen-activated protein kinase 8 (MAPK8) to improve lupus nephritis.
Chai F; Peng H; Qin L; Liu C; Zeng Y; Wang R; Xu G; Wang R; Wei G; Huang H; Lan Y; Chen W; Wang C
Gene; 2024 Jan; 893():147961. PubMed ID: 37931853
[TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway.
You Y; Qin Y; Lin X; Yang F; Li J; Sooranna SR; Pinhu L
BMC Nephrol; 2015 Aug; 16():148. PubMed ID: 26310926
[TBL] [Abstract][Full Text] [Related]
6. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
7. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-182-5p contributes to attenuation of lupus nephritis via Foxo1 signaling.
Wang X; Wang G; Zhang X; Dou Y; Dong Y; Liu D; Xiao J; Zhao Z
Exp Cell Res; 2018 Dec; 373(1-2):91-98. PubMed ID: 30308195
[TBL] [Abstract][Full Text] [Related]
9. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
[TBL] [Abstract][Full Text] [Related]
10. Lupus nephritis reoccurs following transplantation in the lupus prone mouse.
Hamar P; Wang M; Godo M; Kokeny G; Rosivall L; Ouyang N; Heemann U
Lupus; 2010 Feb; 19(2):175-81. PubMed ID: 19946036
[TBL] [Abstract][Full Text] [Related]
11. Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis.
Ding Y; Liao W; Yi Z; Xiang W; He X
Int J Clin Exp Pathol; 2015; 8(10):12646-56. PubMed ID: 26722454
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-145 Involves in the Pathogenesis of Renal Vascular Lesions and May Become a Potential Therapeutic Target in Patients with Juvenile Lupus Nephritis.
Cai Z; Xiang W; Peng X; Ding Y; Liao W; He X
Kidney Blood Press Res; 2019; 44(4):643-655. PubMed ID: 31430759
[TBL] [Abstract][Full Text] [Related]
13. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
Yang H; Xu A; Lv J; Liu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(6):821-5. PubMed ID: 22699062
[TBL] [Abstract][Full Text] [Related]
14. miR-410 suppresses the expression of interleukin-6 as well as renal fibrosis in the pathogenesis of lupus nephritis.
Liu D; Zhang N; Zhang J; Zhao H; Wang X
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):616-25. PubMed ID: 27028192
[TBL] [Abstract][Full Text] [Related]
15. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
16. Expression of glomerular heparan sulphate domains in murine and human lupus nephritis.
Rops AL; van den Hoven MJ; Bakker MA; Lensen JF; Wijnhoven TJ; van den Heuvel LP; van Kuppevelt TH; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2007 Jul; 22(7):1891-902. PubMed ID: 17550924
[TBL] [Abstract][Full Text] [Related]
17. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-183 exerts a protective role in lupus nephritis through blunting the activation of TGF-β/Smad/TLR3 pathway via reducing Tgfbr1.
Qi H; Cao Q; Liu Q
Exp Cell Res; 2020 Sep; 394(2):112138. PubMed ID: 32535034
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
Yao L; Chen HP; Ma Q
Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
[TBL] [Abstract][Full Text] [Related]
20. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice.
Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN
Lupus; 2002; 11(7):411-8. PubMed ID: 12195781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]